Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #690710

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	5,062,000,000 SEK	—	—	—	—	61,000,000 SEK	9,396,000,000 SEK	113,000,000 SEK	1 428,4 SEK	—	7,458,000,000 SEK	13,000,000 SEK	12,628,000,000 SEK	—	5,270,000,000 SEK	—	87,000,000 SEK	—	—	—	6,412,000,000 SEK	1 262,8 SEK	87,000,000 SEK	4,000,000 SEK	6,307,000,000 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	1,938,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1,045,000,000 SEK	—	—	—	—	—	—
Other comprehensive income	—	—	—	0 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	- SEK	—	—	—	—	—	—
Comprehensive income	—	– SEK	– SEK	1,938,000,000 SEK	1,938,000,000 SEK	—	—	—	—	– SEK	—	—	—	– SEK	—	– SEK	—	– SEK	1,045,000,000 SEK	1,045,000,000 SEK	—	—	—	—	—
Issue of equity	—	26,000,000 SEK	– SEK	1,808,000,000 SEK	– SEK	—	—	—	—	1,781,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	– SEK	48,000,000 SEK	48,000,000 SEK	– SEK	—	—	—	—	– SEK	—	—	—	9,000,000 SEK	—	– SEK	—	– SEK	9,000,000 SEK	– SEK	—	—	—	—	—